Pharma Veterans

Navigation Plan for CEOs and Top Executives 2 – Asrar Qureshi’s Blog Post #1059 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1059 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here. Credit: Kampus Production Credit: Mikhail Nilov Preamble This is in continuation with the previous post. The key information and excerpts are taken from McKinsey article. Link at the end. #3 – Leadership Mobilization Checklist • Team Composition – Is my senior team the right size, comprising people with complementary skills and characterized by an ‘enterprise first’ mind? Tough question. A group of high performers becomes truly effective only when its members’ skills complement one another. If it is so, then the overall performance will be bigger than the sum of individual performances. When Asher-Topilsky became the CEO of IDB bank, it was un...

Why Are We Trapped in the Inside View – Mostly? – Asrar Qureshi’s Blog Post #877 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #877 for Pharma Veterans. Pharma Veterans  aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Credit: Samson Katt Credit: Max Rahubovskiy Credit: Pawet L. Scenario – A new product launch is being worked upon. Since it will be at least among the first three launches of this generic, if not the first, there is an air of secrecy around. Only a select few can know what is happening, even fewer who know the progress in real time. Ironically, they do not realize that it is not very difficult to know which company is working on which new product, unless they are cheating the government. Import data is available from customs department which shows the ...